Panel in Japan discusses reimbursement policy for regenerative medicine products with conditional approval
News and discussion for the company Athersys Inc. Discussion of other companies is encouraged
Stroke Technology in 2025: New Treatments Giving Patients a Second Chance
News and discussion for the company Athersys Inc. Discussion of other companies is encouraged
Healios Q1 2025 financial results
News and discussion for the company Athersys Inc. Discussion of other companies is encouraged
Stem cell therapy for dementia: preclinical findings are promising, but significant hurdles must be overcome
News and discussion for the company Athersys Inc. Discussion of other companies is encouraged
Japan's leading ruling party: "Japan's medical care should be communicated to the world"
News and discussion for the company Athersys Inc. Discussion of other companies is encouraged
Healios Analysis Review (May 11, 2025)
News and discussion for the company Athersys Inc. Discussion of other companies is encouraged
Neurologist Dr. Dileep Yavagal: "Stem cell therapy for stroke is still experimental but highly promising"
News and discussion for the company Athersys Inc. Discussion of other companies is encouraged
Major Japanese newspaper calls for quick commercialization of iPS cells
News and discussion for the company Athersys Inc. Discussion of other companies is encouraged
Global efforts in spinal cord injury research: "each milestone counts"
News and discussion for the company Athersys Inc. Discussion of other companies is encouraged
Real-world data: Acute ischemic stroke patients who undergo thrombectomy are at greater risk of new stroke
News and discussion for the company Athersys Inc. Discussion of other companies is encouraged
Autologous stem cells demonstrate positive effect in phase 1 trial for Alzheimer’s disease; Allogeneic stem cells show promise for children with autism
News and discussion for the company Athersys Inc. Discussion of other companies is encouraged
Speculations in Japan regarding Healios
News and discussion for the company Athersys Inc. Discussion of other companies is encouraged
Spanish study: Intraarterial autologous bone marrow cell transplantation within 7 days after stroke may mitigate damage
News and discussion for the company Athersys Inc. Discussion of other companies is encouraged
First use of allogeneic MSCs in treating a US patient shows potential for ataxia improvement
News and discussion for the company Athersys Inc. Discussion of other companies is encouraged
Japan's Rohto starts a domestic phase 2 MSC trial for heart failure
News and discussion for the company Athersys Inc. Discussion of other companies is encouraged
Why did Fidelity acquire 5.29% of Healios recently?
News and discussion for the company Athersys Inc. Discussion of other companies is encouraged
Major media outlet in Japan urges government to further invest in iPS cell research
News and discussion for the company Athersys Inc. Discussion of other companies is encouraged
Ex-Athersys Dr. Tony Ting: "The global MSC community is finally beginning to see the clinical fruits of decades of work"
News and discussion for the company Athersys Inc. Discussion of other companies is encouraged
SanBio optimistic about starting domestic shipments of TBI cell product by end of July; considers conducting TBI and stroke trials in the US
News and discussion for the company Athersys Inc. Discussion of other companies is encouraged
Hardy tweets: Healios plans to file for conditional approval in Japan for stroke
News and discussion for the company Athersys Inc. Discussion of other companies is encouraged
Healios and PMDA agree on inclusion of Japanese patients in the upcoming global Phase 3 ARDS trial
News and discussion for the company Athersys Inc. Discussion of other companies is encouraged
Healios announces its stroke strategy
News and discussion for the company Athersys Inc. Discussion of other companies is encouraged
Japan's Cuorips to suspend culture supernatant business
News and discussion for the company Athersys Inc. Discussion of other companies is encouraged
The Stow facility leased to Refrigeration Sales Corp. Set to open next month
News and discussion for the company Athersys Inc. Discussion of other companies is encouraged
Japanese Biotech Stocks Soar on Regenerative Medicine News; Positive Update from SanBio
News and discussion for the company Athersys Inc. Discussion of other companies is encouraged
